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Abstract 
Background: Mannosylglycerate (MG) is one of the most widespread compatible solutes among marine microor-
ganisms adapted to hot environments. This ionic solute holds excellent ability to protect proteins against thermal 
denaturation, hence a large number of biotechnological and clinical applications have been put forward. However, 
the current prohibitive production costs impose severe constraints towards large-scale applications. All known micro-
bial producers synthesize MG from GDP-mannose and 3-phosphoglycerate via a two-step pathway in which manno-
syl-3-phosphoglycerate is the intermediate metabolite. In an early work, this pathway was expressed in Saccharomy-
ces cerevisiae with the goal to confirm gene function (Empadinhas et al. in J Bacteriol 186:4075–4084, 2004), but the 
level of MG accumulation was low. Therefore, in view of the potential biotechnological value of this compound, we 
decided to invest further effort to convert S. cerevisiae into an efficient cell factory for MG production.
Results: To drive MG production, the pathway for the synthesis of GDP-mannose, one of the MG biosynthetic precur-
sors, was overexpressed in S. cerevisiae along with the MG biosynthetic pathway. MG production was evaluated under 
different cultivation modes, i.e., flask bottle, batch, and continuous mode with different dilution rates. The genes 
encoding mannose-6-phosphate isomerase (PMI40) and GDP-mannose pyrophosphorylase (PSA1) were introduced 
into strain MG01, hosting a plasmid encoding the MG biosynthetic machinery. The resulting engineered strain (MG02) 
showed around a twofold increase in the activity of PMI40 and PSA1 in comparison to the wild-type. In batch mode, 
strain MG02 accumulated 15.86  mgMG g
−1
DCW, representing a 2.2-fold increase relative to the reference strain (MG01). In 
continuous culture, at a dilution rate of 0.15 h−1, there was a 1.5-fold improvement in productivity.
Conclusion: In the present study, the yield and productivity of MG were increased by overexpression of the GDP-
mannose pathway and optimization of the mode of cultivation. A maximum of 15.86 mgMG g
−1
DCW was achieved 
in batch cultivation and maximal productivity of 1.79  mgMG g
−1
DCW h
−1 in continuous mode. Additionally, a positive 
correlation between MG productivity and growth rate/dilution rate was established, although this correlation is not 
observed for MG yield.
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Background
Enzymes and other proteins are used in a myriad of 
applications such as clinical and analytical tests, research, 
therapeutics, vaccines, food processing, textile industry, 
cleaning, and biofuel production. In every case, the pres-
ervation of the native structure under working condi-
tions is a prerequisite for efficacy. While some proteins 
are remarkably robust and can stand harsh conditions 
or repeated work cycles, others require the presence of 
extrinsic stabilizers, or chemical chaperones, to prevent 
unfolding and/or assist refolding. Osmolytes, like glyc-
erol and trehalose, which accumulate inside the cell to 
counterbalance the external osmotic pressure, are well 
known protein protectors [1, 2].
The discovery of marine hyperthermophilic organisms 
in the early 1980s uncovered an untapped source of new 
osmolytes [3]. Microorganisms adapted to those extreme 
environments accumulate exquisite organic solutes, usu-
ally bearing a negative charge, which are absent from 
mesophilic prokaryotes. Importantly, these ionic solutes 
accumulate not only in response to elevated osmotic 
pressure, but also in response to supraoptimal growth 
temperature, suggesting a potential role in thermoprotec-
tion of cell components in vivo [4].
Mannosylglycerate and di-myo-inositol-phosphate are 
the most widespread solutes among marine hyperther-
mophiles [2–5]. In  vitro studies have shown that these 
compounds are better protein stabilizers than trehalose, 
glycerol or any other known neutral solutes [6–11]. In 
particular, MG showed superior performance in a wide 
range of application tests [6–12]. For example, 0.5 M of 
MG resulted in a 7.1 °C increase in the melting tempera-
ture of the model protein, staphylococcal nuclease, while 
the same concentration of glycerol or mannosylglycera-
mide produced increments of < 1  °C and 2.4  °C, respec-
tively [13]. Importantly, we showed that MG was able to 
inhibit formation of α-synuclein inclusions in the cyto-
plasm of yeast cells, a hint of its potential application in 
drug development against protein misfolding diseases 
[13, 14].
All known native producers, Archaea and Bacteria, 
are able to synthesize MG via a two-step pathway: the 
enzyme mannosyl-3-phosphoglycerate synthase cata-
lyzes the reaction of GDP-mannose and 3-phospho-
glycerate into mannosyl-3-phosphoglycerate, which is 
subsequently dephosphorylated by mannosyl-3-phos-
phoglycerate phosphatase to give MG [15, 16]. Empadin-
has et al. [17] noticed that the genome of the mesophilic 
bacterium Dehalococcoides mccartyi (formerly D. ethe-
nogenes), comprised a gene encoding two domains with 
high sequence homology to known mannosyl-3-phos-
phoglycerate synthase and mannosyl-3-phosphoglyc-
erate phosphatase. The same authors confirmed the 
functionality of this gene, designated mgsD, by clon-
ing and expression in Saccharomyces cerevisiae, which 
thereby accumulated intracellular MG up to 7.5  mg  g−1 
cell dry weight [17].
Capitalizing on these results, we deemed it interesting 
to invest further efforts to develop S. cerevisiae into a cell 
factory for MG production. Currently, MG is produced 
by bitop AG (Witten, Germany) through fermentation of 
a natural producer. However, this process has very high 
production costs, preventing the utilization of this com-
pound at an industrial scale or even extensive testing to 
explore new application areas. We selected S. cerevisiae 
as a host organism for the engineering strategy since it 
is a robust industrial workhorse used for the production 
of a wide range of compounds, such as sesquiterpenes, 
bioethanol, artemisinic acid, succinic acid and vanillin 
[18–22].
GDP-mannose and 3-phosphoglycerate are the two 
precursors for the synthesis of MG. We are aware that 
S. cerevisiae’s anabolic pathways imply a high demand 
for GDP-mannose. Indeed, this activated sugar is the 
precursor for protein mannosylation and synthesis of 
oligomannans, important components of the yeast cell 
wall [23, 24]. Therefore, our first engineering strategy 
was intended to enhance the flux towards GDP-man-
nose synthesis by overexpressing the genes encoding 
mannose-6-phosphate isomerase and GDP-mannose 
pyrophosphorylase (Fig. 1). The production of MG by the 
resulting engineered strain was evaluated under different 
cultivation modes, such as flask bottles, controlled batch 
and continuous fermentations at different dilution rates.
Results and discussion
Strain construction and evaluation of gene overexpression
Saccharomyces cerevisiae strain CENPK2-1C was geneti-
cally manipulated to overexpress the genes involved in 
the synthesis of GDP-mannose and MG (Fig.  1). Two 
engineered strains were constructed: (i) the first strain 
(named MG01) harbors the plasmid pDES containing 
the heterologous gene mgsD encoding mannosyl-3-phos-
phoglycerate synthase and mannosyl-3-phosphoglycerate 
phosphatase; and, (ii) the second strain (named MG02), 
in addition to plasmid pDES, harbors the plasmid pSP02 
containing the mannose-6-phosphate isomerase (PMI40) 
and GDP-mannose pyrophosphorylase (PSA1) genes 
from S. cerevisiae. The gene PMI40 was cloned under the 
control of PGK1 promoter and terminator of CYC1, while 
the gene PSA1 was under the promoter of TEF1 and the 
terminator of ADH1. These promoters have previously 
shown high expression levels during growth on glucose 
[25]. To determine the effect of the overexpression of 
PSA1 and PMI40  genes, mannose-6-phosphate isomer-
ase and GDP-mannose pyrophosphorylase activities were 
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measured in the MG02 strain and compared with the 
background strain (S. cerevisiae strain CENPK2-1C). The 
MG02 strain showed an increase of twofold in the man-
nose-6-phosphate isomerase activity and 1.4-fold in the 
GDP-mannose pyrophosphorylase activity in compari-
son with the background strain (Table 1).
Physiological characterization of engineered strains
Cultivation conditions exert a great impact in the perfor-
mance of producing strains. In particular, S. cerevisiae is 
known to accumulate ethanol as a major by-product in 
aerobic conditions under certain circumstances, and 
these different metabolic states may affect the production 
of the desired compound. When there is a low glucose 
uptake rate, S. cerevisiae exhibits a respiratory metabo-
lism only, with no ethanol formation, while, when the 
glucose concentration and/or uptake rate surpasses a 
critical threshold value, the metabolism becomes a com-
bination of respiration and alcoholic fermentation [26]. 
In this work, the engineered strains were grown under 
conditions that imposed a respiratory vs respiro-fer-
mentative metabolism; the fitness and MG accumulation 
parameters were determined under these conditions.
Physiological characterization of engineered strains 
in shake flasks and batch bioreactors
The engineered strains were initially characterized 
in shake flasks using synthetic complete medium 
(SC medium) with 20  g  L−1 of glucose. MG01 and 
MG02 exhibited similar growth rates (0.24  h−1 for 
MG01 vs 0.25  h−1 for MG02), but biomass produc-
tion was different: 0.13 ± 0.01  gDCW  g−1glc for MG01 and 
0.10 ± 0.00  gDCW  g−1glc for MG02. Profiles of growth, glu-
cose consumption, ethanol, glycerol and acetate produc-
tion are shown in Additional file 1: Figure S1 indicates a 
higher production of ethanol and growth for strain MG01 
but the same production of glycerol and acetate for both 
strains. The intracellular content of MG was determined 
after glucose depletion and, under these conditions, 
Fructose-6P
GDP-mannoseMannosylglycerate
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PiGDP + Pi
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Fig. 1 Biosynthesis of mannosylglycerate (MG) in Saccharomyces cerevisiae using glucose as carbon source. MG is produced from the reaction 
of GDP-mannose and 3-phosphoglycerate (3PG) with the release of GMP. To produce MG, a gene from Dehalococcoides mccartyi coding for MG 
synthase/phosphatase (mgsD) was cloned in a plasmid and transformed in S. cerevisiae to yield strain MG01. A second plasmid containing the genes 
PMI40 (encodes a mannose-6-phosphate isomerase) and PSA1 (encodes a GDP-mannose pyrophosphorylase) from S. cerevisiae was constructed 
and transformed in MG01 yielding MG02
Table 1 Mannose-6-phosphate isomerase (PMI40) 
and  GDP-mannose pyrophosphorylase (PSA1) activities 
in the background and MG02 strains
CENPK2-1C (U/mg 
of protein)
MG02 (U/mg 
of protein)
Increase 
(n-fold)
Mannose-
6-phosphate 
isomerase
120 ± 1 244 ± 10 2.0
GDP-mannose 
pyrophos-
phorylase
45 ± 7 65 ± 14 1.4
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MG02 showed a 1.5-fold increase in MG production 
compared to the reference strain MG01. A comparison 
between shake flask and controlled bioreactor for both 
strains is depicted in Additional file 1: Table S1. S. cerevi-
siae GDP-mannose pool had been successfully increased 
before by the over-expression of the gene MPG1 (PSA1) 
in a multi-copy plasmid [23]. In the present work, it was 
possible to increase MG production by over-expressing 
PSA1 (MPG1) and PMI40, which re-directed part of the 
glycolytic flux towards the formation of GDP-mannose 
and consequently to MG.
In order to check whether MG accumulation could be 
enhanced by a controlled environment, strains MG01 
and MG02 were grown in a 2-L bioreactor. In controlled 
batch cultivation, MG02 produced 15.86  mg  g−1DCW of 
MG, which represents an increase of 2.2-fold in compari-
son to MG01 (Fig.  2a). In controlled batch cultivation, 
using a bioreactor, it is possible to maintain optimal con-
ditions regarding pH, concentration of oxygen and tem-
perature. Under these conditions, strain MG02 produced 
higher amounts of MG than in shake flasks. Moreover, 
MG01 and MG02 showed no detectable difference in the 
production of end-products ethanol, glycerol and acetate 
(Fig. 2b).
Physiological characterization of engineered strains 
in chemostat at different dilution rates
Since the relative contribution of respiratory and respiro-
fermentative regimens in S. cerevisiae depends on 
glucose availability, it is difficult to achieve a pure respira-
tory regimen in controlled batch cultivations. Therefore, 
a clear distinction of the two metabolic states is only pos-
sible in fed-batch and chemostat cultures. In an aerobic 
environment and in the presence of high concentrations 
of glucose, S. cerevisiae has a fermentative/respiratory 
metabolism due to a limited respiratory capacity [26]. 
In addition, there is a molecular response whereby the 
TCA cycle is repressed and the metabolic flow towards 
fermentation products is increased, a phenomenon des-
ignated as the Crabtree effect [27]. This behavior hap-
pens independently of the presence of oxygen to support 
respiration and is seen as an adaptive response to a com-
petitive environment, as fermentation increases S. cerevi-
siae’s growth rate. Nevertheless, it is possible to ensure 
a respiratory metabolism as long as the glucose uptake 
rate is kept below the critical threshold that activates 
fermentation.
To investigate the impact of the respiratory and fermen-
tative states in MG production, both strains were grown 
in chemostats at a dilution rate of 0.1 h−1, where, in prin-
ciple, respiration is favored and the production of ethanol 
is reduced (or even abolished) [28]. Under these condi-
tions, the yield of MG is consistently higher for MG02 in 
comparison with MG01 (Table  2) and MG productivity 
is 0.76 mg g−1DCW h−1 for MG01 and 1.17 mg g−1DCW h−1 for 
MG02, which represents a 1.5-fold increase. However, it 
is apparent that the two strains display different meta-
bolic modes, as MG01 has a Respiratory Quotient (RQ) 
of 1.39, a value close to fully respiratory metabolism [29], 
while MG02 has an RQ value of 2.32, which denotes a 
respiro-fermentative metabolism. This result is also cor-
roborated by the accumulation of higher amounts of 
ethanol and glycerol in MG02 (Table 2). Despite the RQ 
differences, the biomass yield under these conditions 
remains the same for both strains. Most likely, the differ-
ences in by-products accumulation are not high enough 
to provoke an observable decrease in the biomass yield, 
given the experimental error. Therefore, we conclude 
0
5
10
15
20
MG01 MG02
Y M
G
/X
 (m
g M
G
.g
D
W
-1
) 
a b 
0
2
4
6
8
10
12
MG01 MG02
En
d-
pr
od
uc
ts
 (g
.L
-1
) 
Acetate Glycerol
Ethanol
Fig. 2 MG production and end-products formation observed for strains MG01 and MG02 in controlled batch cultivations. a MG production on 
biomass for strains MG01 and MG02. Cells were grown in SC medium with 20 g L−1 of glucose and MG content was assessed after glucose was 
depleted from the medium. b Ethanol, glycerol, and acetate production of strains MG01 and MG02. Data represents the mean ± SD of three 
independent experiments
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that the higher production of MG or/and directly the 
over-expression of PSA1 and PMI40 correlate with a sig-
nificant decrease of the respiratory capacity of the cell. 
Although no previous work has reported the physiologi-
cal impact of overexpressing these two genes, it would be 
counter-intuitive to assume that a diversion of part of the 
glycolytic flux would increase by-product accumulation.
Additionally, the ionic nature of MG might be unbal-
ancing cell homeostasis and therefore reducing cell fit-
ness for MG02, as 15.86  mgMG  g−1DCW represents an 
intracellular concentration of approximately 25  mM, 
which is a substantial value for an organism that intrin-
sically accumulates non-charged osmolytes, like glycerol 
and trehalose [1, 30]. Increasing concentrations of MG 
produces an acidification of the cytoplasm (pKa of MG is 
3.35) which can compromise growth [31, 32] and impair 
essential metabolic functions [33]. S. cerevisiae cultivated 
in aerobic conditions with glucose as carbon source, 
switches from respiratory-fermentative growth to mainly 
fermentative growth in the presence of high concentra-
tions of acetic acid, that shares with MG the characteris-
tics of a weak acid. Under these conditions, a significant 
decrease in the specific rate of  O2 consumption was 
observed while high level of  CO2 were maintained 
[36], as observed for the MG02 strain. Additionally, the 
metabolic shift to a fermentative behavior (higher RQ) 
observed in MG02 has been described before for other 
inhibiting compounds such as furfural, a compound 
known to inhibit glycolytic enzymes, react with cellular 
constituents and compromise the respiratory activity [34, 
35], although the mechanisms of action are probably dif-
ferent from weak acids.
Additionally, steady-state MG02 cells cultivated under 
a dilution rate of 0.1  h−1 showed a profile of ethanol 
production that is largely influenced by the concentra-
tion of ethanol produced during growth in the batch 
mode. Chemostat experiments were initiated with dif-
ferent ethanol concentrations, which apparently pro-
duced different results for the ethanol concentration 
at steady-state, explaining the high standard deviation 
associated with ethanol production observed in Table 2. 
However, the rate of ethanol decrease from the begin-
ning of the chemostat until steady-state is very similar 
for both experiments (see Additional file  1: Figure S2). 
The fact that the initial ethanol concentration is not fully 
washed from the bioreactor during the continuous cul-
tivation at low dilution rates may be another indication 
that both strains are not in full respiratory regimen [37]. 
However, the influence of initial ethanol concentration in 
continuous cultures in the respiratory capacity has not 
been, to our knowledge, previously reported and remains 
unexplained.
To evaluate the impact of increasing the dilution rate, 
we performed chemostat experiments at dilution rates 
close to the maximum (washout) values (0.15  h−1 for 
MG02 and 0.2  h−1 for MG01). The difference between 
MG01 and MG02 in MG production observed at 0.1 h−1 
is kept, while the productivity of both strains in chemo-
stats at 0.1 h−1 dilution rate is lower when compared to 
chemostats performed close to maximal dilution rates 
(Additional file 1: Table S2). Curiously, MG yield on bio-
mass is not influenced by the variation on the dilution 
rate, either for MG01 or MG02, although for MG02 the 
MG yield on substrate is larger for the lower dilution rate.
In order to understand the role of different metabolic 
states in the production of MG and to gain insight into 
the respiratory capacity, cells from MG02 were cultivated 
in a chemostat at dilution rate of 0.05  h−1 to allow for 
fully respiratory mode. A comparison of the three dilu-
tion rates for this strain shows that, as expected, the bio-
mass yield on glucose decreases with high dilution rates 
(Fig. 3a). In aerobic glucose-limited chemostat cultures, it 
is well-known that when yeast cells are cultivated at high 
rates (close to the maximal growth rate), the flux from 
glycolysis is re-directed to the production of by-prod-
ucts (e.g. ethanol) and respiration is kept at lower levels. 
However, when the dilution rate is reduced, respiration 
becomes the major source of energy through TCA cycle 
and consequently, the production of biomass increases 
[37]. Also, by gradually decreasing the dilution rate in 
MG02, we verified a decrease in the production rate of 
MG (Fig.  3b). However, there is no correlation between 
the dilution rate and MG yield on glucose (Fig.  3c) or 
even production on biomass (remains the same for 
dilutions 0.15 and 0.1  h−1 (Additional file  1: Table  S2) 
and decreases to 8.21  mgMG  g−1DCW at dilution 0.05  h−1). 
Table 2 Physiological parameters and  MG yield for  the  engineered strains MG01 and  MG02 in  chemostat cultivation 
at dilution rate 0.1 h−1
a Yields on biomass for substrate  YX/S are represented as  gDCW g
−1
glc and yields on substrate for ethanol  YEtOH/S, acetate  YAcet/S and glycerol  YGly/S are represented as g g
−1
glc
b MG production on biomass  YMG/X is represented as  mgMG g
−1
DCW
c Productivity in chemostat cultivation for MG is represented as mg g−1DCW h
−1
Strain YaX/S Y
b
MG/X Y
a
EtOH/S Y
a
Acet/S Y
a
Gly/S P
c
MG/X
MG01 0.13 ± 0.02 7.58 ± 1.21 0.17 ± 0.03 0.05 ± 0.01 0.001 ± 0.001 0.76 ± 0.12
MG02 0.15 ± 0.02 11.71 ± 0.77 0.33 ± 0.31 0.04 ± 0.02 0.013 ± 0.001 1.17 ± 0.08
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Despite the lack of correlation with dilution, MG seems 
to reach a peak of production in terms of yield per sub-
strate at 0.1  h−1 dilution rate (Fig.  3c). In light of these 
results, we can conclude that MG production does not 
respond linearly to a variation on the growth rate; how-
ever, as cells are growing more rapidly, MG productiv-
ity is higher at higher dilution rates. Another important 
result is the variation of RQ values with the dilution rates 
examined. Coherently with previously published results 
[29], RQ decreases at lower dilutions and strain MG02 
is virtually at a fully respiratory state at dilution 0.05 h−1 
(Fig.  3d), corroborated by the absence of glycerol pro-
duction and decrease on acetate/ethanol yields which 
dropped to 0.1 g g−1glc.
Continuous mode chemostat presents several advan-
tages in comparison with batch cultures and it is a valua-
ble approach to explore the best conditions for industrial 
production. One advantage, which is exploited in this 
work, is the evaluation under controlled conditions of 
physiological parameters based on growth rates [38]. 
The cultivation of S. cerevisiae in respiro-fermentative 
metabolic mode holds some issues as it is accompanied 
by the accumulation of by-products and low biomass 
yield. Additionally, ethanol production might interfere 
with the productivity of compounds by provoking toxic-
ity [39]. For this reason, industrial bioprocesses usually 
use a dilution rate of 0.1 h−1 or lower [38] as is the case 
of resveratrol production [40]. Nonetheless, the respiro-
fermentative metabolism favors the production of certain 
compounds. In a recent study, the cultivation conditions 
for ethylene production were optimized and were found 
to be coupled with the growth rate [41]. MG is produced 
from GDP-mannose and 3-phosphoglycerate (3PG), 
both derived from glycolysis. As the respiro-fermentative 
metabolism of S. cerevisiae implies a higher glycolytic 
flux than respiration, it is reasonable to speculate that 
MG production would increase with higher growth rates 
in chemostat. Additionally, it has been described that 
PSA1 is an essential gene linked to the progression of cell 
cycle, since efficient glycosylation of proteins is a key-
point for cell division [42]. Even more, PSA1 transcript 
levels increase with higher growth rates [43], which may 
favor the synthesis of GDP-mannose and ultimately 
the synthesis of MG. In the present work, this correla-
tion between MG production and growth rates was not 
observed. The fact that MG production was not depend-
ent on growth rate may indicate that there is a bottleneck 
downstream of GDP-mannose, i.e., in the production of 
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Fig. 3 Effect of dilution rate in the formation of biomass, MG production rate and respiratory quotient (RQ) for MG02 (mgsD ↑pmi40 ↑psa1). 
Chemostats were performed in 2-L fermenters containing SC medium with 20 g L−1 glucose. a Biomass yield on substrate, represented as 
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−1
glc, b MG productivity represented as  mgMG g
−1
DCW h
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MG which is catalyzed by the bifunctional enzyme man-
nosylglycerate synthase/phosphatase.
Conclusions
In this study, we have increased the yields and produc-
tivity of mannosylgycerate (MG), a protein stabilizer 
with outstanding properties, by over-expressing PSA1 
and PMI40 (GDP-mannose pathway) and by optimizing 
the mode of cultivation. The resulting strain MG02 pre-
sents up to 2.2-fold improvement in MG production on 
biomass, being able to produce 1.79 mg of MG per gram 
of biomass per hour at a dilution of 0.15 h−1. Also, it was 
not possible to establish a correlation between growth 
rate and MG yield on substrate, although MG productiv-
ity increases with higher dilution rates. New rounds of 
optimization are needed to produce MG in S. cerevisiae 
at adequate levels, i.e., well above the values reported for 
organisms that naturally produce this compound. For 
instance, evaluate the overexpression of SEC53 gene and 
improve the expression of MG synthase. To this end, a 
holistic approach should be considered, based on in silico 
driven metabolic engineering to find gene targets that 
will improve MG production.
Methods
DNA manipulation
Saccharomyces cerevisiae genomic DNA for colony PCR 
and gene amplification was prepared as described by 
Lõoke et  al. [44]. Primers were purchased from Meta-
bion (Germany). Gene amplification and colony PCR 
were performed using, respectively, Phusion polymerase 
and DreamTaq DNA polymerase (both enzymes from 
Thermoscientific, USA). PCR reactions were performed 
in a Thermal Cycler from Bio-Rad (USA), following the 
protocols recommended by the manufacturers for each 
polymerase. Plasmid extraction, PCR product purifi-
cation, and DNA gel extraction were carried out with 
Zymo Research kits (USA). All restriction enzymes were 
obtained in fast-digestion format from Thermoscientific 
(USA). The plasmid pDES, containing the gene mgsD that 
codes for mannosyl-3-phosphoglycerate synthase/phos-
phatase from D. mccartyi under the control of the ENO2 
promoter from enolase II, was kindly provided by Milton 
S. da Costa (University of Coimbra, Portugal) [17]. S. cer-
evisiae transformation was performed using the lithium 
acetate method as described by Gietz et al. [45]. Escheri-
chia coli DH5α was used for plasmid isolation and main-
tenance following the competence and transformation 
procedures developed by Dower et al. [46].
Construction of engineered strains
The plasmid pSP-GM was kindly provided by Prof. Jens 
Nielsen’s group (Chalmers University of Technology, 
Sweden) [25]. This plasmid was used to express the man-
nose-6-phosphate isomerase (PMI40) and GDP-mannose 
pyrophosphorylase (PSA1) encoding genes from S. cer-
evisiae. The gene PMI40 was amplified using genomic 
DNA isolated from S. cerevisiae strain CENPK2-1C with 
the primers pair 5′-CCG CGG CCG CAA AAA AAT GTC 
CAA CAA GCT GTT CAG G-3′ and 5′-CCG AGC TCC 
TAA TTT GGT TCC ACA AAGGC-3′. This PCR product 
was digested with SacI/NotI and ligated into pSP-GM 
between promoter of TEF1 and terminator of ADH1 
using a T4 ligase (Thermoscientific, USA), yielding 
pSP01. Next, the gene PSA1 was amplified using again S. 
cerevisiae strain CENPK2-1C genomic DNA with prim-
ers pair 5′-GGC CCG GGA AAA AAA TGA AAG GTT 
TAA TTT TAG TCG G-3′ and 5′-CCA AGC TTT CAC ATA 
ATA ATA GCT TCC TTT GG-3′. This PCR product was 
digested with HindIII/XmaI and ligated into pSP01 using 
a T4 ligase between promoter of PGK and terminator of 
CYC1, resulting in plasmid pSP02. Colonies harboring 
pSP01 and pSP02 were identified by performing colony 
PCR with the primers used in the amplification. Correct 
constructions of plasmids were confirmed by restric-
tion analysis and DNA sequencing (GATC Biotech, 
Germany).
The strain S. cerevisiae CENPK2-1C, obtained from 
EUROCARF (Germany), was used as the host strain in 
this work. The strain MG01 was obtained by transform-
ing CENPK2-1C cells with plasmid pDES (conferring 
yeast cells the ability to produce MG); strain MG02 was 
obtained by transforming MG01 with plasmid pSP02, 
leading to a strain combining GDP-mannose overpro-
duction and MG synthesis (Table 3).
Strain maintenance and cultivation media
Selection and maintenance of plasmids in E. coli was 
performed in LB medium containing 10  g  L−1 of pep-
tone, 10 g L−1 of NaCl, 5 g L−1 of yeast extract, and sup-
plemented with 100  mg  L−1 of ampicillin. The solid LB 
medium also included 20 g L−1 of agar. All cultivations of 
E. coli were carried out at 37 °C and 200 rpm of agitation.
Saccharomyces cerevisiae strain CENPK2-1C (MATa 
ura3-52 his3-Δ1 leu2-3,112 trp1-289, MAL2-8c SUC2) 
was cultivated in YPD medium, containing 10  g  L−1 of 
yeast extract, 20 g L−1 of peptone, and 20 g L−1 of glucose, 
at 30 °C and 160 rpm. Recombinant strains were selected 
on Synthetic complete (SC) medium containing 6.7 g L−1 
of yeast nitrogen base without amino acids from Difco 
(USA), 20  g  L−1 of glucose and 20  g  L−1 of agar. When 
necessary, histidine (20 mg L−1), tryptophan (20 mg L−1), 
uracil (20 mg L−1) and leucine (30 mg L−1), were added to 
cover auxotrophies. All cultivations of S. cerevisiae were 
performed at 30 °C with 160 rpm agitation.
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The SC medium used for shake flasks, batch in con-
trolled bioreactors, and continuous cultivation contained 
6.7  g  L−1 of yeast nitrogen base without amino acids 
from Difco (USA) supplemented with 20  g  L−1 of glu-
cose. For strain MG01, SC medium was supplemented 
with histidine (20 mg L−1), tryptophan (20 mg L−1), and 
uracil (20 mg L−1), while for strain MG02 it was comple-
mented only with histidine and tryptophan, in the same 
concentrations [48]. For shake flask cultivations, MG01 
and MG02 were pre-grown in 50  mL of SC medium at 
30  °C and 160  rpm. Then, cells were used to inoculate 
500  mL shake flasks containing 100  mL of SC medium 
with an initial  OD600 of 0.1. Growth was followed using a 
spectrophotometer V-560 from Jasco (Japan); cells were 
harvested at the end of the exponential phase (24 h upon 
inoculation).
Batch cultivations were performed as following: firstly, 
cells were grown overnight in shake flasks from a single 
colony. Each fermenter was inoculated at an initial  OD600 
of 0.1. The batch fermentations were performed in a BIO-
STAT-B Plus system (Sartorius, Germany) coupled with 
a 2-L culture vessel. The operating conditions are the fol-
lowing: the fermentation volume was 0.8 L, the tempera-
ture was maintained at 30 °C, the airflow was 1 vvm, the 
pH was kept at 5.5 controlled by addition of 2 M NaOH, 
and the dissolved  O2 was kept above 30% of saturation by 
feedback control of the stirring speed from 200 rpm up 
to 600 rpm. Concentrations of  O2 and  CO2 in the exhaust 
gas were monitored by Bluesens gas analyzers (Germany) 
and RQ represents the ratio between  CO2 produced and 
 O2 consumed during fermentation. Biological samples 
were collected at the end of the exponential phase, when 
 CO2 production dropped drastically.
Continuous cultivations were also carried out in a Sar-
torius BIOSTAT-B Plus system coupled with a 2-L cul-
ture vessel with a constant working volume of 0.8 L, with 
the same controlled variables and set-points as before. 
The medium described above was used to feed the bio-
reactor at dilution rates of 0.05, 0.1, 0.15 and 0.2 h−1. The 
volume was kept at 0.8 L by controlling the level of broth 
inside the vessel. To guarantee that the culture reached 
a steady-state mode, at least 5 volumes of medium were 
allowed to pass through the culture whenever the dilu-
tion rate was changed. Samples were collected when  O2 
consumption and  CO2 production were constant.
Quantification of MG, biomass and fermentation end 
products
For each sampling, 50 mL of broth were removed from 
the culture and centrifuged at 3600×g for 10  min to 
separate cells from the medium. Next, the supernatant 
was filtered through a membrane filter with a pore 
size of 0.22 μm into HPLC vials and stored at − 20 °C 
until further analyzed for glucose, glycerol, acetate, 
and ethanol. MG is an intracellular compound and was 
extracted from the cell pellet by adding 5 mL of water, 
5 mL of methanol and 10 mL of chloroform. This mix-
ture was vigorously shaken with the help of a vortex 
and then centrifuged at 12,000×g for 30  min at 4  °C. 
The top part, corresponding to the aqueous phase, was 
carefully transferred to a new tube and the process of 
centrifugation was repeated after the addition of 5 mL 
of water. Once the aqueous phase was separated, sam-
ples were evaporated using a Savant™ SPD131DDA 
SpeedVac (Thermoscientific, USA). Next, the evapo-
rated samples were dissolved in 1  mL of water and 
transferred to an HPLC vial. Analysis was performed 
in an HPLC apparatus from Jasco (Japan) model LC-
NetII/ADC equipped with UV-2075 Plus and RI-2031 
Plus detectors, also from Jasco. The samples were ana-
lyzed using an Aminex HPX-87H column from Bio-
Rad, which was kept at 50 °C, and a solution of 0.01 M 
Table 3 List of strains and plasmids used in this work
LEU2, leucine auxotrophy; mgsD, mannosyl-3-phosphoglycerate synthase/phosphatase gene; ENO2, gene enolase II; URA3, uracil auxotrophy; PMI40, mannose-6-
phosphate isomerase gene; PSA1, GDP-mannose pyrophosphorylase gene
Relevant characteristics References
Strains
 CEN.PK2-1C Wild-type strain (MATa; his3D1; leu2-3_112; ura3-52; trp1-289; MAL2-8c; SUC2) [47]
 MG01 CEN.PK2-1C with plasmid pDES to allow MG production This work
 MG02 CEN.PK2-1C with plasmid pDES and plasmid pSP02 to overexpress genes from GDP-mannose pathway This work
Plasmids
 pDES pRS425 plasmid backbone with LEU2 as auxotrophic marker. Contains mgsD gene from D. mccartyi under the con-
trol of the promotor ENO2 from S. cerevisiae
[17]
 pSP-GM pESC plasmid backbone with URA3 as auxotrophic marker. Harbors TEF1 and PGK promoters from S. cerevisiae [25]
 pSP01 pSP-GM with PMI40 gene from S. cerevisiae This work
 pSP02 pSP-GM with PSA1 and PMI40 genes from S. cerevisiae This work
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of  H2SO4 was used as the mobile phase with a flow rate 
of 0.3 mL min−1. Quantitative analysis of glucose, MG, 
glycerol, acetate and ethanol was performed by com-
parison with a mixture of standards with known con-
centrations of each metabolite. MG standards were 
obtained from cell biomass of Rhodothermus marinus 
as previously described [49]. Calibration curves were 
prepared using the peak areas of the RI detector for 
glucose, glycerol, acetate and ethanol and of the UV 
detector at 210  nm for MG. The cell dry weight was 
determined by filtering 5 mL of culture broth through 
a 0.22 μm pore Millipore filter and washing once with 
5  mL of water. Filters were then dried for 10  min at 
150  W in a microwave oven and weighted using an 
analytical balance.
Quantification of enzymatic activities
For the determination of mannose-6-phosphate 
isomerase and GDP-mannose pyrophosphorylase activ-
ities, strains WT and MG02 were grown in shake flasks 
until mid-exponential phase. Cells were harvested by 
centrifugation and re-suspended in water with a cock-
tail of protein inhibitors (1×), following manufacturer’s 
instructions (Roche, USA). Next, cells were broken with 
three pulses of vortexing (4.0  m  s−1 for 60  s) using a 
Fastprep 24 system (MP, USA), keeping cells on ice for 
5 min between each pulse. Supernatants were obtained 
by centrifugation at 13,500×g for 5  min and used to 
determine enzymatic activities. Total protein was 
determined using the Bradford method [50]. The spec-
trophotometric methods used to determine the enzy-
matic activities have been described by Bergmeyer [51]. 
Briefly, for the mannose-6-phosphate isomerase activ-
ity, the assay mixture (final volume of 1 mL) contained: 
50  mM Tris–HCl (pH 7), 5  mM mannose-6-phos-
phate, 8  mM  MgCl2, 2.8  mM NADP, 0.27 U glucose-
6-phosphate dehydrogenase, 0.27 U phosphoglucose 
isomerase, and 0.25 mg of cell extract. Reactions were 
started by the addition of mannose-6-phosphate and 
absorbance was measured at 340 nm for 2 min. For the 
GDP-mannose pyrophosphorylase activity, the assay 
mixture (final volume of 1  mL) contained: 50  mM of 
Tris–HCl (pH 7), 0.5 mM NaF, 10 mM  MgCI2, 0.1 mM 
ADP, 1 mM glucose, 1 mM NADP, 2 mM PPi, 5.5 mM 
GDP-mannose, 1 U each of nucleoside kinase, hexoki-
nase, and glucose-6-P dehydrogenase, and 0.25  mg 
of cell extract. The reaction was started by the addi-
tion of GDP-mannose, and the formation of NADPH 
was monitored by recording the absorbance at 340 nm 
for 2  min. One unit corresponds to the conversion of 
1 µmol of substrate per minute.
Additional file
Additional file 1: Figure S1. Growth and end-products formation of 
the strains MG01 (A) and MG02 (B) cultivated in shake flask with SC 
medium containing 20 g L−1 of glucose. Data represent the mean of three 
independent experiments. Gly—glycerol; Acet—acetate; EtOH—ethanol. 
Table S1. MG and end-products production and yields for the engineered 
strains MG01 (mgsD) and MG02 (mgsD ↑pmi40 ↑psa1) cultivated in shake 
flask and batch fermenters. Data represent the mean ± SD of at least three 
independent experiments. Table S2. Physiological parameters and MG 
yields for the engineered strains MG01 (mgsD) and MG02 (mgsD ↑pmi40 
↑psa1) in chemostat cultivation at different dilution rates. Figure S2. 
Profile of glucose consumption, acetate, glycerol, ethanol and MG produc-
tion from the beginning until steady-state for strains MG01 (A) and MG02 
(B) cultivated in two independent chemostats (experiment 1 and 2) with 
dilution 0.1 h−1.
Abbreviations
DCW: dry cell weight; OD600: optical density measured at 600 nm; LB medium: 
Luria–Bertani medium; SC medium: synthetic complete medium; SD: standard 
deviation; MG: mannosylglycerate; 3PG: 3-phosphoglycerate; vvm: gas volume 
flow per unit of liquid volume per minute; RQ: respiratory quotient.
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